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Abstract 
 
The role of Melanocortin 2 Receptor (MC2R) in adrenal/interrenal glucocorticoid 
secretion has been well documented in many organisms. Studies in mammals have shown 
that in the adrenal gland two melanocortin receptors and two melanocortin receptor 
accessory proteins are expressed: MC2R, MC5R, MRAP, and MRAP2. The MRAPs 
have an opposite effect on the cell surface expression of MC2R and MC5R. In mammals, 
MRAP aids MC2R but inhibits MC5R cell surface expression. This thesis aims to explore 
the functional relationship between MC2R, MC5R, MRAP, and MRAP2 in Xenopus 
tropicalis to determine if the MRAPs have a similar effect on amphibian MC2R and 
MC5R when the receptors are stimulated with ACTH, or -MSH. Expression of these 
four genes in the frog interrenal was verified through RT-PCR. Then CHO-K1 cells were 
transfected with plasmid constructs containing X. tropicalis MC2R, MC5R, MRAP2, and 
a mouse MRAP, and stimulated with ACTH or -MSH. Levels of receptor activation 
were measured using a CRE-luciferase reporter gene. The findings presented here 
indicate that in the frog the MRAPs do not have a negative effect on MC5R, since 
activation of MC5R was not inhibited in the presence of MRAPs. The sensitivity of 
MC5R for ACTH increased from an EC50 of 1.2 x 10
-9
 M to an EC50 of 8.7 x 10
-11
 M in 
the presence of MRAP (p<0.05) and to an EC50 of 1.3 x 10
-10
 M in the presence of 
MRAP2 (p<0.01).  
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 1 
Introduction 
The mammalian melanocortin system is composed of five distinct melanocortin 
receptors: MC1R-MC5R, two accessory proteins: MRAP and MRAP2, the melanocortin 
ligands: ACTH, --and -MSH, and two endogenous antagonists: agouti and AGRP. 
Melanocortin Receptors (MCRs) 
Melanocortin receptors (MCRs) belong to the Class A family of G-protein 
coupled receptors (GPCRs), which fall under the same family as the rhodopsin/2-
adrenergic-like receptors (Rodrigues et al., 2013). A common characteristic of all GPCRs 
is that they consist of seven -helical transmembrane-spanning domains that are 
connected by alternating intracellular and extracellular loops (Rosenbaum et al., 2006). 
MCRs couple to an intracellular heterotrimeric G-protein, with a stimulatory G subunit 
that when activated will stimulate the production of cyclic adenosine monophosphate 
(cAMP) via adenylyl cyclase (Figure 1). This intracellular buildup of cAMP, will 
generate downstream signaling through activation of protein kinase A (PKA) (Gantz and 
Fong, 2003; Rosenbaum et al., 2006). MCRs are considered to be the smallest GPCRs 
that have been identified since they have short domains in the extracellular N-terminal 
and intracellular C-terminal, small fourth and fifth transmembrane-spanning domains, 
and a very small second extracellular loop (Mountjoy et al., 1992). Currently, five 
melanocortin receptors have been cloned, and they are numbered consecutively in the   
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Figure 1: GPCR/adenylyl cyclase signaling transduction pathway. Signaling begins 
when the ligand/hormone binds to the G-protein coupled receptor (GPCR) and this causes 
a conformational change in the intracellular heterotrimeric G-protein. This results in the 
activation of the G-subunit that will stimulate adenylyl cyclase to produce cAMP. 
cAMP will build up in the cytoplasm and act as a second messenger to activate protein 
kinase A (PKA). 
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order of their discovery: MC1R, MC2R, MC3R, MC4R, and MC5R (Rodrigues et al., 
2013). These receptors are involved in a wide range of physiological functions such as 
skin and hair pigmentation, inflammation, glucocorticoid secretion, energy homeostasis, 
appetite regulation, sexual function, and sebaceous gland secretion (Yang, 2011). 
Proopiomelanocortin (POMC): The precursor for the MCR ligands.  
Proopiomelanocortin (POMC) is placed under the opioid/orphanin gene family 
and it is a precursor for -endorphin, lipotropin, and the melanocortin ligands (Dores et 
al., 2002). POMC is predominantly expressed in the pituitary and the hypothalamus 
(Benjannet et al., 1991) as well as keratinocytes, melanocytes and some peripheral tissues 
such as GI-tract, adrenal, spleen, lung, thyroid and some cells of the immune system 
(Gantz and Fong, 2003). In the anterior pituitary, POMC is expressed by the corticotropic 
cells and processed into ACTH and -lipotropin; whereas in the intermediate pituitary the 
melanotropic cells will process POMC into --and -MSH, -endorphin, and 
corticotropic-like intermediate lobe peptide (CLIP) (Dores et al., 2002). POMC is a 
biologically inactive molecule until it undergoes proteolytic cleavage at specific pairs of 
amino acids by enzymes known as prohormone convertases PC1/3 and PC2 (Benjannet et 
al., 1991; Catania et al., 2004). As shown in Figure 2, these enzymes will process POMC 
to yield the melanocortin ligands, which are the melanocyte stimulating hormones -
MSH, -MSH, and -MSH, and adrenocorticotropic hormone (ACTH). The processing of 
POMC is tissue specific and different cell types will produce different melanocortin 
ligands depending on which enzymes, PC1/3, PC2, and other processing enzymes are 
present (Gantz and Fong 2003). A common feature of the melanocortin ligands is that  
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Figure 2: Processing of Proopiomelanocortin (POMC). Enzymes involved in the 
posttranslational processing of POMC in the pituitary to produce the melanocortin 
ligands ACTH, -MSH, -MSH, and -MSH (Figure from Patel et al., 2011).   
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they all share the His-Phe-Arg-Trp (HFRW) motif (Catania et al., 2004), which is 
required for proper activation of MCRs as well as the Lys-Lys-Arg-Arg-Pro (KKRRP) 
motif in ACTH (Costa et al., 2004; Liang et al., 2013). MCRs have a varying degree of 
affinity for the ligands that are derived from the precursor peptide hormone POMC, as 
well as for two known antagonists: agouti and agouti-related peptide (AGRP) (Table 1) 
(Gantz and Fong, 2003). 
Activation of Mammalian MC1R, MC3R, MC4R and MC5R by the POMC derived 
ligands 
Out of all the melanocortin ligands, MC1R seems to have the highest affinity for 
-MSH (Gantz and Fong, 2003). MC1R is mainly expressed in melanocytes (Mountjoy 
et al., 1992) where it mediates skin and hair pigmentation. MC1R has also been found in 
other cell types such as keratinocytes, fibroblasts, endothelial cells, and other immune 
cells (Gantz and Fong, 2003). Some studies have also investigated the involvement of 
MC1R in the anti-inflammatory process (Catania et al., 1996; Lipton and Catania, 1997). 
MC3R has been linked to energy homeostasis due to its expression in the regions 
of the central nervous system (CNS) known to control feeding behavior. It is largely 
expressed in the cortex, thalamus, hippocampus, hypothalamus, GI-tract, and placenta. It 
can bind ACTH and the MSH-ligands roughly with equal affinity (Gantz et al., 1993; 
Gantz and Fong 2003).  
Similar to MC3R, MC4R is expressed in the CNS and is also involved in energy 
homeostasis, in addition to the regulation of sexual function (Gantz and Fong, 2003).  
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Table 1: Function of the melanocortin receptors, ligands, and antagonists. Ligand 
selectivity of the receptors for the proopiomelanocortin (POMC) derived ligands: 
melanocyte stimulating hormones (--and -MSH), and adrenocorticotropic hormone 
(ACTH). Agouti has the ability to bind and antagonize all the receptors, with the 
exception of MC5R. Agouti-related peptide (AGRP) can potentially regulate the activity 
of MC3R and MC4R. There is no known antagonist for MC5R. 
Receptor Ligand selectivity Antagonists Function 
MC1R -MSH=ACTH > -MSH > -MSH Agouti 
Pigmentation, 
inflammation 
MC2R ACTH Agouti Steroidogenesis 
MC3R -MSH=-MSH = -MSH=ACTH Agouti, AGRP Energy homeostasis 
MC4R -MSH=ACTH > -MSH > -MSH Agouti, AGRP 
Energy homeostasis, 
erectile function 
MC5R -MSH > ACTH > -MSH > -MSH  
Sebaceous gland 
secretion 
 *Adapted from Gantz and Fong, 2003. 
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Deleting this receptor in mice, results in an obese phenotype consistent with hyperphagia, 
hyperinsulinemia, and hyperglycemia, which suggests that MC4R plays a role in 
regulating feeding behavior (Huszar et al, 1997). 
The last melanocortin receptor to be cloned was MC5R. This receptor has a wide 
range of tissue distribution with detectable expression levels in skeletal muscle, brain, 
RT2-2 retinal neuronal cells, lung, spleen, kidney, testis, heart, liver (Fathi et al., 1995) 
and adrenal gland (Sebag and Hinkle, 2009a). Also, it has been detected in numerous 
exocrine tissues like Harderian gland, lacrimal, preputial, and sebaceous glands (Chen et 
al., 1997). There is not much is currently known about the function of this receptor in all 
of these tissues. However, its role in exocrine gland secretion was determined by targeted 
deletion of MC5R in mice, and the observation that mutant mice exhibited defects in 
thermoregulation due to decreased surface lipids, along with decreased secretion of 
proteins from the lacrimal gland, and a deficiency of porphyrin from the Harderian glands 
compared to wild type littermates (Chen et al., 1997). In mammals, this receptor seems to 
have a preference for -MSH (Gantz and Fong 2003).  
Melanocortin 2 Receptor (MC2R): The ACTH-Receptor 
MC2R was the second melanocortin receptor to be characterized (Mountjoy et al., 
1992). MC2R is expressed in murine adipocytes (Catania et al., 2004), but it is primarily 
involved in stress regulation via the Hypothalamic-Pituitary-Adrenal (HPA) Axis. MC2R 
is also known as the ACTH-receptor because it exclusively binds ACTH, and unlike the 
other MCRs, it does not bind any of the MSH-ligands (Gantz and Fong, 2003). MC2R is 
expressed in the adrenal cortex zona fasciculata and part of the zona glomerulosa, which 
are sites involved in the synthesis and release of glucocorticoids (Mountjoy et al., 1992; 
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Xia and Wikberg, 1996). The finding that roughly 25% of individuals with a rare disease, 
known as Familial Glucocorticoid Deficiency (FGD) Type 1, have mutations in MC2R 
supports the involvement of this receptor in regulating glucocorticoid secretion (Chung et 
al., 2008). Some of the phenotypes associated with individuals suffering from FGD are 
low levels of cortisol (a glucocorticoid), insensitivity to ACTH, hypoglycemia, 
susceptibility to infections, and intense skin pigmentation. This disease can be fatal in 
early childhood if left untreated (Metherell et al., 2005; Chung et al., 2008). 
Another unique aspect of MC2R is that since its discovery in 1992, many 
researchers failed to functionally express MC2R in heterologous mammalian cell lines 
unless the receptor was expressed in an adrenal-derived cell line. Noon et al. (2002) were 
the first to suggest that MC2R must require an adrenal-specific accessory factor, such as 
a chaperone, that enabled proper trafficking to the plasma membrane and activation by 
ACTH. This observation was based on the fact that the same epitope-tagged version of 
the receptor would function properly if expressed in an adrenal cell line, but not in other 
cell types. Thus, MC2R must be interacting with another “cofactor” that is specifically 
expressed in adrenal cells. A few years later that interacting partner was identified and 
named Melanocortin 2 Receptor Accessory Protein (MRAP).  
Melanocortin 2 Receptor Accessory Protein (MRAP)  
The eventual discovery of MRAP was done by comparing individuals with FGD 
Type 2 and their unaffected family members through microarray analysis of SNPs, and 
this revealed a region on a chromosome that codes for a small protein that is now known 
as Melanocortin 2 Receptor Accessory Protein (MRAP) (Metherell et al., 2005). 
Individuals are diagnosed with FGD Type 2 because they lack mutations in MC2R, but 
9 
regardless of having an intact receptor they still display phenotypes associated with FGD, 
such as resistance to ACTH and a deficiency in cortisol production. Metherell et al. 
(2005) also proved that this small protein consists of a single transmembrane-spanning 
domain. When MRAP is coexpressed with MC2R in a non-adrenal cell line, it allows for 
the proper trafficking of MC2R to the plasma membrane as well as activation by ACTH. 
Further studies on the structure of this protein have shown that MRAP forms homodimers 
(Cooray et al., 2008) and that these two proteins are oriented in an anti-parallel manner 
with one MRAP being oriented with its N-terminal facing the exterior environment and 
the other MRAP with its N-terminal facing the cytoplasm. These dual orientations of 
MRAP homodimers form a stable interaction with MC2R (Sebag and Hinkle, 2007). 
A homologue of MRAP was later discovered, called MRAP2, which is 39% 
identical to MRAP in amino acid sequence at the N-terminal and transmembrane domain 
(Chan et al., 2009). MRAP2 can interact with MC2R in vitro and enables receptor 
trafficking to the cell surface, but it is not nearly as efficient as MRAP when the cells are 
stimulated with ACTH (Chan et al., 2009; Sebag and Hinkle 2010). MRAP2 is similar to 
MRAP in that it also consists of a single transmembrane-spanning domain, forms 
homodimers, and can form a heterodimer with MRAP (Chan et al., 2009); but differs in 
that it lacks an important LDYI motif, which is necessary for MC2R activation by ACTH 
(Sebag and Hinkle, 2009b). These two accessory proteins interact with all five MCRs and 
have the potential to regulate their function by increasing/decreasing cell surface 
expression, in addition to the ligand affinity of the receptor (Chan et al., 2009; Cerdá-
Reverter et al., 2013).   
10 
Studies on the evolutionary origin of MCRs propose that MCRs are the result of 
two genome duplication events and one local gene duplication that occurred during the 
evolution of the chordates. The evolution of MCRs is also closely linked to the co-
evolution of POMC, MRAPs, and the AGRP/ASIP gene families (Dores, 2013). The 
discovery of an MRAP-independent MC2R in the cartilaginous fish Callorhinchus milii, 
which can be functionally activated by either ACTH or any of the MSH-ligands (Reinick 
et al., 2012), suggests that the ancestral MC2R must have been MRAP-independent. As 
mutations accumulated in both MC2R and MRAP, the receptor and the accessory protein 
developed a functional relationship where MRAP is required to facilitate MC2R 
trafficking to the plasma membrane and activation by ACTH (Dores, 2013). This 
interaction of MC2R with MRAP, and the ligand selectivity for ACTH has been well 
established not only for mammals, but also for birds (Barlock et al., 2014), fish 
(Agulleiro et al., 2010), and amphibians (Liang et al., 2011).   
The Hypothalamic-Pituitary-Adrenal (HPA) Axis  
In mammals, the Hypothalamic-Pituitary-Adrenal (HPA) Axis is a regulated 
system of signaling events that lead to the synthesis and release of glucocorticoids from 
the adrenal cortex in a circadian pattern and in response to organismal stress. Signaling 
begins after the parvocellular neurons in the hypothalamus release corticotropin-releasing 
hormone (CRH) directly into the median eminence of the anterior pituitary via the 
Pituitary Portal Vein. CRH will bind to receptors on corticotropic cells where ACTH will 
be synthesized and released into the vascular system. Then ACTH will bind to and 
activate MC2R in the glucocorticoid producing cells in the adrenal cortex leading to the 
synthesis and release of cortisol (Figure 3). Glucocorticoids will induce several  
11 
 
Figure 3: The Hypothalamic-Pituitary-Adrenal (HPA) Axis. The cerebral cortex will 
signal the hypothalamus to release corticotropin-releasing hormone (CRH) directly to the 
anterior pituitary, where the precursor hormone proopiomelanocortin (POMC) will be 
processed into ACTH and released into the bloodstream. ACTH will reach the adrenal 
gland and will induce the synthesis and release of cortisol. Cortisol will reach its target 
tissues and will also negatively feedback (-) to stop the release of CRH in the 
hypothalamus and to stop the synthesis and release of ACTH in the pituitary.   
 
*Illustration adapted with artist permission (Samson, 2012). 
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physiological changes in the organism such as improvement in motor reflexes, cognitive 
function, alertness, pain tolerance, and decreased appetite and sexual arousal. 
Glucocorticoids will also regulate the HPA-axis, through a negative feedback loop, in 
order to stop the release of CRH in the hypothalamus and to stop the synthesis and 
release of ACTH in the pituitary (For review see Papadimitriou and Priftis, 2009).        
The HPA-axis is an evolutionary conserved response to stress and a similar 
system exists in fish and amphibians. The interrenal tissue in the head kidney of fish and 
the interrenal tissue in amphibians is the equivalent to the adrenals in mammals; 
therefore, in these species the HPA-axis is referred to as the Hypothalamic-Pituitary-
Interrenal (HPI) Axis. The interrenal tissue contains the glucocorticoid producing cells 
and stress activation is also in response to ACTH via an MRAP-dependent MC2R. 
A closer look at the Adrenal/Interrenal 
MC2R and MC5R are coexpressed in the mammalian adrenal gland (Sebag and 
Hinkle, 2009a) and in the interrenal tissue of fish (Kobayashi et al., 2011), which is 
relevant to this study because despite the presence of MC5R, -MSH does not induce 
glucocorticoid secretion in vivo (Kobayashi et al., 2011; Aluru and Vijayan 2008). In the 
mammalian adrenal gland, the two accessory proteins MRAP and MRAP2 are also 
expressed (Sebag and Hinkle, 2009a) and studies dating back to the 1970’s have shown 
that α-MSH does not stimulate the mammalian adrenal cortex to release glucocorticoids 
(Schwyzer, 1977). 
In trying to characterize the functional interaction of these proteins, Sebag and 
Hinkle (2009a) found that MC2R requires MRAP for trafficking to the plasma 
membrane, but when MC5R was coexpressed with either of the accessory proteins, 
13 
MRAP or MRAP2, the receptor failed to reach the cell surface and was trapped in the 
endoplasmic reticulum (ER) (See Figure 4). Based on their observations it seems that in 
the mammalian system MC2R will preferentially bind MRAP to reach the cell surface 
and to be activated by ACTH, and the interaction of MC5R with either MRAP or 
MRAP2 will have a negative effect on the receptor by interfering with the ability of the 
receptor to dimerize (Figure 4). These observations raise some interesting questions about 
how the stress response has evolved and how these proteins might interact in other 
systems such as in fish and amphibians. 
Objectives and Hypotheses 
This study will use Xenopus tropicalis as a model system to test the hypothesis 
that the interaction of MC2R, MC5R, MRAP, and MRAP2 in the interrenal tissue of 
amphibians is similar to that previously reported for the mammalian adrenal gland. It is 
hypothesized that all of these proteins will be found in the interrenal tissue of the frog. 
Therefore, it is expected that MRAP will aid MC2R translocation to the plasma 
membrane and activation by ACTH, but MRAP or MRAP2 will prevent MC5R from 
reaching the cell surface and this will inhibit activation by either ACTH or -MSH. It is 
also hypothesized that MRAP does exist in the Xenopus tropicalis genome. In the 
genome of Xenopus tropicalis all five receptors and MRAP2 have been sequenced, but 
the sequence for MRAP has not yet been identified. This will be accomplished through 
RNA extraction, cDNA synthesis, and PCR on the interrenal tissue of Xenopus tropicalis 
using gene specific primers for MC2R, MC5R, and MRAP2, and degenerate primers 
from conserved regions of MRAP.  
  
14 
This study will also make use of an in vitro approach doing transient transfections 
with CHO cells and using different combinations of cDNA constructs of Xenopus 
tropicalis MC2R, MC5R, MRAP2 and Mus musculus MRAP to test the interaction of 
these proteins. To measure cAMP production upon stimulation with ACTH or -MSH, 
the CHO cells will also be transfected with a CRE-Luciferase reporter gene.  
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Figure 4: Observations from Sebag and Hinkle (2009) on the opposite effect that 
MRAP/MRAP2 have on MC2R and MC5R. A. MRAP and MRAP2 will promote 
trafficking of MC2R to the plasma membrane. However, MRAP is much more effective 
and required for activation of MC2R by ACTH. B. MRAP and MRAP2 will prevent 
dimerization of MC5R and will prevent the receptor from reaching the cell surface. C. In 
the adrenal cell all four: MC2R, MC5R, MRAP, and MRAP2 are expressed, but it is still 
not well understood how these four proteins interact.  
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Materials and Methods 
Total RNA extraction  
Mature female Xenopus tropicalis, six months or older, were purchased from 
Nasco (Modesto, CA) for tissue dissection. The frogs were first anesthetized with MS-
222 (Sigma-Aldrich) followed by decapitation. Tissues were extracted and frozen 
immediately on dry ice and stored at -80C for subsequent use in RNA extraction. Tissue 
dissections were done by Dr. Robert Dores and approved by the University of Denver 
Institutional Animal Care and Use Committee (IACUC Approval #472436-1).   
A section of interrenal/kidney tissue (between 50-100mg) was used for total RNA 
extraction using 1mL of TRIzol Reagent in a glass-Teflon homogenizer. After the 
tissue was homogenized on ice, it was transferred into a 1.75mL microcentrifuge tube 
and was centrifuged at 12,000 x g for 10 minutes at 4C. The supernatant was transferred 
to a clean microcentrifuge tube and incubated at room temperature for 5 minutes. 200L 
of phenol-chloroform-isoamyl alcohol was added and the tube was shaken vigorously by 
hand. After 3 minutes at room temperature, the sample was centrifuged again at 12,000 x 
g for 15 minutes at 4C and the upper aqueous phase, which contains the RNA, was 
transferred into to a clean microcentrifuge tube. The RNA was precipitated by using 
500L isopropyl alcohol and incubated at room temperature for 10 minutes, followed by 
centrifugation at 12,000 x g for 10 minutes at 4C.  The supernatant was removed and the 
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RNA pellet was washed with 1mL RNase-free 75% EtOH, vortexed briefly, and then 
centrifuged at 7,500 x g for 5 minutes at 4C. The RNA pellet was air dried for 10 
minutes, and dissolved in 30L RNase-free water. Afterwards, DNA-free DNase 
Treatment & Removal (Ambion, Life Technologies) was used to remove any genomic 
DNA contamination in the sample. The total RNA was treated with 1L 10x DNase I 
Buffer and 1L rDNase I and incubated at 37C for 30 minutes. Then 2L of DNase 
Inactivation was added, incubated at room temperature for 2 minutes and centrifuged at 
10,000 x g for 1.5 minutes. The supernatant was transferred to a clean microfuge tube, 
leaving the pellet with any genomic DNA contamination behind. RNA concentration was 
measured using NanoDrop 2000 Spectrophotometer (Thermo Scientific), and the tube 
was stored at -80C.  
The same protocol was repeated using 50-100mg of Xenopus tropicalis heart, 
brain, liver, muscle, ovaries, and intestinal tissue for expression patterns of MC2R, 
MC5R, MRAP, and MRAP2 through cDNA synthesis and PCR.  
cDNA Synthesis 
cDNA synthesis was performed using SuperScript III First Strand Synthesis 
System for RT-PCR (Invitrogen) following manufacturer’s instructions. The reaction was 
carried out using Oligo(dT)20 primer and 0.5g of total RNA was used per reaction. For 
the negative control, reverse transcriptase was omitted from the reaction components.   
PCR 
Gene specific primers were designed for X. tropicalis MC2R, MC5R, and 
MRAP2 from sequences obtained from www.xenbase.org and www.ncbi.nlm.nih.gov.  
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Degenerate primers were designed for MRAP based on regions of sequence conservation 
for the MRAP sequences of human, mouse, chicken, rat, rhesus macaque, rainbow trout, 
and Chinese soft-shelled turtle. The primers were ordered from Integrated DNA 
Technologies (www.idtdna.org).  Primer sequences, annealing temperature (Ta), and 
expected size PCR products are listed in Table 2. A standard 20L PCR reaction was set 
up using 2L 10X PCR buffer, 0.6L 50mM MgCl2, 2L 10mM dNTPs, 2L 10M 
Forward Primer, 2L 10M Reverse Primer, 0.2L Taq Polymerase 5U/L (Invitrogen), 
9.2L sterile water, and 2-3L interrenal/kidney cDNA or negative control. A positive 
control was also set up with plasmid cDNA constructs containing the full-length 
xtMC2R, xtMC5R, and xtMRAP2. Five 20l PCR reactions were done for each gene. 
The cycling parameters for the thermal cycler were: initial denaturation at 94C for 3 
minutes, a second denaturation at 94C for 45 seconds, primer annealing for 30 seconds, 
primer extension at 72C for 1 minute and 30 seconds, cycle 32 times to second 
denaturation step, a final extension at 72C for 10 minutes, and reaction was held at 4C. 
The PCR reactions for each respective gene were combined and purified using QIAquick 
PCR purification kit (Qiagen). 5L 6X loading dye was added to each PCR reaction and 
the PCR products were ran at 60 Volts for 1 hour on a 2% TAE gel stained with Ethidium 
Bromide for visualization using Quantity One Gel Doc Imager (BioRad). exACTGene 
Low Range Plus DNA Ladder (Fisher Scientific) was used to verify the size of products. 
The bands were excised from the gel based on the expected product length and purified 
using Wizard SV Gel and PCR Clean-Up System (Promega) and stored at -20C. If PCR  
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Table 2: Sequences of X. tropicalis gene specific PCR primers for MC2R, MC5R, 
MRAP2, and degenerate PCR primers for MRAP. Annealing temperature (Ta) for each 
primer pair and expected size of PCR product in base pairs (bp). 
 
 
 
 
 
 
Gene Primer Sequence Ta Size 
xtMC2R 
Forward: 
5’ GGTGCTCCTAGCTGTGATAAA 3’ 
Reverse: 
5’ GGAGACCAACAGCAAATGAATA 3’ 
59.8C 594 bp 
xtMC5R 
Forward: 
5’ AATACAGTGCCAACTGGAAAG 3’ 
Reverse: 
5’ CTTCATGCTTGTTCTCTGGTG 3’ 
61.6C 645 bp 
xtMRAP 
Degenerate Forward: 
5’ ATGGCCAACRGRACMRACKCMTCTG 3’ 
Degenerate Reverse: 
5’ CRGGACATGTAGAGCARRATRARRAA 3’ 
61.6C 185 bp 
xtMRAP2 
Forward: 
5’ AAGCAGTTGTCCAATTCTGATTAC 3’ 
Reverse: 
5’ GAGAGACCGTGATTCTTCTGTT 3’ 
57C 312 bp 
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yielded a faint band, the excised band that was purified was submitted through another 
round of PCR to increase product yield.  
Ligation and Bacterial Transformation 
The purified gel products: MC2R, MC5R, MRAP, and MRAP2 were ligated into 
pGEM-T Easy Vector System I (Promega) using 3L of PCR product and left overnight 
at 4C. Mix & Go Competent DH5 E. coli cells (Zymo Research) were used for 
transforming 3-5L of each of the ligations according to manufacturer’s instructions. The 
cells were plated on LB-Agar+Carbenicillin/X-gal/IPTG and incubated overnight at 
37C. Colonies were selected based on blue/white screening and insert was verified using 
PCR with SP6 and T7 primers. White colonies were picked with a sterile toothpick and 
resuspended in microfuge tubes with 20L sterile water. They were heated for 2 minutes 
at 96C and 2L was added to a tube containing PCR mix (as previously described, but 
with an extra 5L sterile water). The same PCR cycling parameters mentioned above 
were used, but with a primer annealing temperature of 55C. A 20L aliquot was taken 
from each PCR reaction and stored at 4C and the remaining 5L were run on a 2% TAE 
gel to verify the correct size of insert in the plasmid. The 20L PCR reactions for the 
colonies that were positive for the insert were treated with 0.5L Exonuclease I (USB) 
and 0.5L Shrimp Alkaline Phosphatase (USB) and incubated at 37C for 45 minutes and 
at 80C for 45 minutes to degrade any remaining primers and dNTPs. These PCR 
samples were sent for sequencing with SP6 or T7 primer at the University of Colorado 
DNA Sequencing & Analysis Service.  
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Cell Line 
Adherent Chinese Hamster Ovary cells (CHO-K1) from ATCC, were grown in a 
25cm
2
 cell culture flask with a vented cap with CHO Media prepared by using Kaighn’s 
Modification of Ham’s F-12 Medium (F-12K) supplemented with 10% Fetal Bovine 
Serum, 1% penicillin/streptomycin, and 1 mg/ml Normocin(InvivoGen). The cells were 
maintained in a 37C incubator with a relative humidity of 80-90%, and 5% CO2. CHO 
cells were sub-cultured when they reached about 90% confluence. The media was 
removed and the cells were rinsed with 3 mL 1X phosphate buffered saline (PBS). 2mL 
of Trypisn/0.53mM EDTA was added and incubated at 37C for 3 minutes to aid cell 
detachment. Then 3 mL fresh CHO media was added to inactivate the trypsin. The cells 
were either counted with a hemocytometer for use in transfection experiments, or a small 
aliquot was subcultured in a new flask with fresh media being renewed between 
subcultures. 
Plasmid Constructs 
cDNA plasmid constructs were synthesized by GenScript (Piscataway, NJ) in a 
pcDNA3.1(+) vector: Xenopus tropicalis MC2R with a FLAG epitope tag at the N-
terminal, Xenopus tropicalis MC5R, Xenopus tropicalis MRAP2 with a FLAG epitope 
tag at the N-terminal, Mus musculus MRAP, Xenopus tropicalis MC5R mutant with 
alanine substitutions at positions 92, 114, and 119, Xenopus tropicalis MC2R mutant 
with an alanine substitution at isoleucine 175 (xtMC2R I-175), and a Gallus gallus 
MRAP with a FLAG epitope tag at the N-terminal. 
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cAMP Assay using a CRE-Luciferase Reporter Gene 
CHO cells were transiently transfected using the Amaxa Nucleofector II Device 
and the Cell Line Nucleofector Kit T (Lonza). For each transfection 2.5x106 cells were 
used with 100L of Solution T and 2g of different combinations of cDNA plasmid 
constructs. All transfections contained 2g of the CRE-Luciferase Reporter cDNA 
plasmid construct, kindly donated by Dr. Patricia M. Hinkle. The cells were transfected 
using Program U-023. After transfection, the cells were allowed to recover for 10 
minutes in 500L of CHO media in the 37C incubator. Then the cells were diluted in 
7.5mL of CHO media and plated in a 96-well plate at a density of approximately 1x10
5
 
cells per well. Each transfection was plated, three columns per transfection, so each plate 
could hold a total of four transfections. The plate was placed in the 37C incubator with 
fresh media being replaced 24 hours after transfection. 48 hours post-transfection the 
cells were stimulated with varying peptide concentrations of frog ACTH 1-24 or frog -
MSH prepared in Serum-Free CHO Medium (F-12K Medium, 1 mg/ml BSA, and 1% 
penicillin/streptomycin). The stimulating solutions ranged in concentration from the 
control, which was Serum-Free CHO Medium only, and 10
-12
 M to 10
-6
 M. Each 
concentration was done in triplicates. After a period of four hours in the 37C incubator,  
the plate was allowed to sit at room temperature for 10 minutes. The stimulating solutions 
were removed and 100L of a 1:1 ratio of Serum-Free CHO Medium and luciferase 
substrate (Bright-Glo Luciferase Assay System, Promega) was added to each well. After 
five minutes at room temperature, luminescence was read using the Bio-Tek Synergy HT 
Plate Reader. For each transfection the average control value was subtracted from each 
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experimental value, and the mean for each data point was graphed using KaleidaGraph 
Software. A Micahelis-Menten curve was fit through the data points to obtain an EC50 
value as well as standard error. Comparison of the EC50 values were done using a 
Student’s t-test with equal variance and significance set at p<0.05.  
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Results 
Cloning MC2R, MC5R, MRAP, and MRAP2  
PCR on interrenal/kidney tissue 
PCR was performed using cDNA synthesized from X. tropicalis interrenal/kidney 
tissue in order to verify the presence of MC2R, MC5R, MRAP, and MRAP2 (Figure 5).  
The interrenal tissue was difficult to extract without taking a small portion of the kidney, 
so it is labeled as interrenal/kidney tissue. A band consistent with the expected product 
size was observed for each gene: MC2R (594bp), MC5R (645bp), MRAP (185bp), and 
MRAP2 (312bp). No visible band was detected in any of the negative controls (Lane 1: 
5A, 5B, 5C, 5D), which had all the RT-PCR components with the exception of reverse 
transcriptase. The band for each gene that was amplified from the cDNA was excised 
from the gel, ligated into a vector, and sequenced to confirm that the primers had 
amplified the gene of interest. Figure 6 shows the full-length nucleotide and amino acid 
sequence of MC2R with the primer regions in bold and the underlined 594 base pair 
region that was verified through sequencing. The same was done for MC5R (Figure 7) 
and underlined is the 645 base pair region that was sequenced, as well as the 312 base 
pair region that was sequenced for MRAP2 (Figure 8). For MRAP, a 185 base pair region 
was amplified with the degenerate primers and when sequenced matched the chicken 
MRAP. An alignment of the nucleotide and amino acid sequence was done to show 
sequence homology between the chicken MRAP and the sequence that was obtained from
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Figure 5: Gel electrophoresis of PCR fragments of MC2R, MC5R, MRAP, and MRAP2 
(A-D) using cDNA synthesized from X. tropicalis interrenal/kidney tissue. Ladder (L) 
sizes in base pairs (bp) listed on the right panel. A. MC2R (594 bp): Lane 1-Negative 
control (no reverse transcriptase (RT)), Lane 2-Positive control-plasmid containing full-
length xtMC2R insert, Lane 3- cDNA. B. MC5R (645 bp): Lane 1-Negative control (no 
RT), Lane 2-Positive control-plasmid containing full-length xtMC5R insert, Lane 3- 
cDNA. C. MRAP (185 bp): Lane 1-Negative control (no RT), Lane 2- cDNA. D. 
MRAP2 (312 bp): Lane 1-Negative control (no RT), Lane 2-Positive control-plasmid 
containing full-length xtMRAP2 insert, Lane 3- cDNA. 
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Figure 6: X. tropicalis MC2R nucleotide and amino acid sequence. Underlined sequence 
shows the 594 base pair region sequenced from the interrenal/kidney tissue. Sequences in 
bold indicate the forward and reverse primer target sequences. 
 
MC2R 
atggatatagcaaatgaaatcggaaggcaacacactggtatgaagaatgtgacaatcctg  
 M  D  I  A  N  E  I  G  R  Q  H  T  G  M  K  N  V  T  I  L     20 
 
tcagtgaacagcacaaaatgttccagcgttcatgttccagaggtggtgtacctaaccgta   
 S  V  N  S  T  K  C  S  S  V  H  V  P  E  V  V  Y  L  T  V     40 
                              FORWARD PRIMER  
tctgctattggtctcctggaaaatctgctggtgctcctagctgtgataaaaaataaaaat  
 S  A  I  G  L  L  E  N  L  L  V  L  L  A  V  I  K  N  K  N     60 
 
cttcacttgcccatgtactttttcatttgtagtttggcagtctccgatatgctgttcagt   
 L  H  L  P  M  Y  F  F  I  C  S  L  A  V  S  D  M  L  F  S     80 
 
ctatacaaaattctcgagaccattataataattttagccaacattggtttcctggataga   
 L  Y  K  I  L  E  T  I  I  I  I  L  A  N  I  G  F  L  D  R    100 
 
aatgggcctttcgaaaaaaagatggatgatgtaatggactggatctttgttctttcatta   
 N  G  P  F  E  K  K  M  D  D  V  M  D  W  I  F  V  L  S  L    120 
 
cttggatcaatctttagcatatctgcgattgcagctgacagatacattactgtttttcat   
 L  G  S  I  F  S  I  S  A  I  A  A  D  R  Y  I  T  V  F  H    140 
 
gcactgcattaccataatatcatgactgtaaaaagagcttcagtcatattagcagtaatt   
 A  L  H  Y  H  N  I  M  T  V  K  R  A  S  V  I  L  A  V  I    160 
 
tggacattttgtggtggaagtggaatagctataattatgctgtttcatgatacggcaatg   
 W  T  F  C  G  G  S  G  I  A  I  I  M  L  F  H  D  T  A  M    180 
 
ataatatgtctcactgttatgttcctattattattagttttgatagtttgcctttacatc   
 I  I  C  L  T  V  M  F  L  L  L  L  V  L  I  V  C  L  Y  I    200 
 
catatgtttcttctagctcgatcacatgccaaaaaaattgcatctctatccggacaatgg   
 H  M  F  L  L  A  R  S  H  A  K  K  I  A  S  L  S  G  Q  W    220 
 
aattctgttcagcaacgggctaacataaatggagcgattactttgaccattttacttgga   
 N  S  V  Q  Q  R  A  N  I  N  G  A  I  T  L  T  I  L  L  G    240 
       REVERSE PRIMER 
ctattcatttgctgttggtctccatttgttctgcatcttctgttatatgtattatgccga   
 L  F  I  C  C  W  S  P  F  V  L  H  L  L  L  Y  V  L  C  R    260 
 
tataatccatattgtgcctgttatttgtccatgttaaatgtgaacggtacacttatattg   
 Y  N  P  Y  C  A  C  Y  L  S  M  L  N  V  N  G  T  L  I  L    280 
 
tttagttctgttattgaccctttaatttatgcttttcgcagccccgagctacgcaatacc   
 F  S  S  V  I  D  P  L  I  Y  A  F  R  S  P  E  L  R  N  T    300 
 
ttcaaaaaaatgttatgctgttggatgacaatgtag 
 F  K  K  M  L  C  C  W  M  T  M  -                            311 
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Figure 7: X. tropicalis MC5R nucleotide and amino acid sequence. Underlined sequence 
shows the 645 base pair region sequenced from the interrenal/kidney tissue. Sequences in 
bold indicate the forward and reverse primer target sequences.  
MC5R 
atgaatttatctctgcagcaatctactctagaacttaatataagtagcttgctaggaaat   
 M  N  L  S  L  Q  Q  S  T  L  E  L  N  I  S  S  L  L  G  N     20  
FORWARD PRIMER  
aatacagtgccaactggaaagactaagtcctcagcatgtgagcaagtggtaatagctgca   
 N  T  V  P  T  G  K  T  K  S  S  A  C  E  Q  V  V  I  A  A     40 
 
gaagttttcctcacacttggcattgtgagtctcctagaaaacattctagtcatctttgca   
 E  V  F  L  T  L  G  I  V  S  L  L  E  N  I  L  V  I  F  A     60 
 
attataaagaacaagaatttgcattcacctatgtacttttttgtatgtagcttagcagtc    
 I  I  K  N  K  N  L  H  S  P  M  Y  F  F  V  C  S  L  A  V     80 
 
gccgacatgttagttagtgtttccaatgcttgggaaaccattacaataaatctgatcaac   
 A  D  M  L  V  S  V  S  N  A  W  E  T  I  T  I  N  L  I  N    100 
 
aacaggcatctaattatggaagagacttttgtacgtcatattgacaatgtttttgattcg   
 N  R  H  L  I  M  E  E  T  F  V  R  H  I  D  N  V  F  D  S    120 
 
atgatttgtatatctgtggtggcttccatgtgcagcttgctggctatagcagtcgataga   
 M  I  C  I  S  V  V  A  S  M  C  S  L  L  A  I  A  V  D  R    140 
 
tatgtcaccatattttatgctctacgttaccataacattatgactatgagaagagctgga   
 Y  V  T  I  F  Y  A  L  R  Y  H  N  I  M  T  M  R  R  A  G    160 
 
atcatcatagcatgcatatggaccttttgcacaggatgtgggatcatcttcatactttat   
 I  I  I  A  C  I  W  T  F  C  T  G  C  G  I  I  F  I  L  Y    180 
 
tatgaatcaacatatgttataatatgtcttattacaatgtttttcactatgctttttctc   
 Y  E  S  T  Y  V  I  I  C  L  I  T  M  F  F  T  M  L  F  L    200 
 
atggtgtccttatatatacacatgttcttgttggctcgtactcatgttaagagaatagca   
 M  V  S  L  Y  I  H  M  F  L  L  A  R  T  H  V  K  R  I  A    220 
                             REVERSE PRIMER 
gccttacctggttacaattcagttcaccagagaacaagcatgaagggagccattacctta   
 A  L  P  G  Y  N  S  V  H  Q  R  T  S  M  K  G  A  I  T  L    240 
 
accatactgcttggcatttttattgtctgctgggcccctttttttctccaccttattttg   
 T  I  L  L  G  I  F  I  V  C  W  A  P  F  F  L  H  L  I  L    260 
 
atgatttcctgtcctcaaaatctttattgtgtgtgttttatgtcccatttcaatatgtac   
 M  I  S  C  P  Q  N  L  Y  C  V  C  F  M  S  H  F  N  M  Y    280 
 
ctgatactaataatgtgcaattctgtaattgatcctatgatttatgcgtttcgtagtcaa   
 L  I  L  I  M  C  N  S  V  I  D  P  M  I  Y  A  F  R  S  Q    300 
 
gaaatgcgaaaaacttttaaagaaattatttgctgctatagcctgcgaatgttttgtgac   
 E  M  R  K  T  F  K  E  I  I  C  C  Y  S  L  R  M  F  C  D    320 
 
ttgcctagcaaatattaa   
 L  P  S  K  Y  -                                              325 
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Figure 8: X. tropicalis MRAP2 nucleotide and amino acid sequence. Underlined 
sequence shows the 312 base pair region sequenced from the interrenal/kidney tissue. 
Sequences in bold indicate the forward and reverse primer target sequences. 
 
 
 
 
 
 
MRAP2 
                                                                                FORWARD PRIMER  
atgtctgaacaaactgttcaaacaaacagaacatcacataagcagttgtccaattctgat   
 M  S  E  Q  T  V  Q  T  N  R  T  S  H  K  Q  L  S  N  S  D     20  
 
tacacatgggaatatgaatactacgaatatgcgcctgtttcatttgaaggattaaaagct   
 Y  T  W  E  Y  E  Y  Y  E  Y  A  P  V  S  F  E  G  L  K  A     40 
 
cataaatactcaattgtaattggattctgggttggtcttgcagtctttgtcatattcatg   
 H  K  Y  S  I  V  I  G  F  W  V  G  L  A  V  F  V  I  F  M     60 
 
ttctttgttttgactttgttggccaagacaggagctcctcatcaagaaaatgttgattca   
 F  F  V  L  T  L  L  A  K  T  G  A  P  H  Q  E  N  V  D  S     80 
 
ttggagaaacaattcagaatggacagttttgcgcctgattttggaaggaacactgaagct   
 L  E  K  Q  F  R  M  D  S  F  A  P  D  F  G  R  N  T  E  A    100 
                                   REVERSE PRIMER 
gacactgacagaattttctctcgcaatgtaacagaagaatcacggtctctctttcactgc   
 D  T  D  R  I  F  S  R  N  V  T  E  E  S  R  S  L  F  H  C    120 
 
tacattaatgaagtggaccagccagaaagaataaagaacaggaacagagccatggacaat   
 Y  I  N  E  V  D  Q  P  E  R  I  K  N  R  N  R  A  M  D  N    140 
 
gaaattatcattcagcaaaccattagaaattccaaggtagaagaggacattaatatgatt   
 E  I  I  I  Q  Q  T  I  R  N  S  K  V  E  E  D  I  N  M  I    160 
 
gcaaagttcaacatccctaactttgttaacacagaccagagttcttcaattggtgatgat   
 A  K  F  N  I  P  N  F  V  N  T  D  Q  S  S  S  I  G  D  D    180 
 
gaccttctattatatgatccaccaatgaatttggaaaacaaagcagtccatactagtttg    
 D  L  L  L  Y  D  P  P  M  N  L  E  N  K  A  V  H  T  S  L    200 
 
tgtgactttatgaactga   
 C  D  F  M  N  -                                              205 
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the MRAP degenerate PCR primers (Figure 9). The regions targeted by the primers are in 
bold and sequence identity is highlighted in gray. The region that was sequenced from the 
frog interrenal/kidney tissue contains the region of MRAP that is responsible for 
trafficking to the plasma membrane and the transmembrane spanning domain (Liang et 
al., 2011). 
Expression of MC2R, MC5R, MRAP, MRAP2 in other tissues 
The same PCR conditions that were used for the interrenal/kidney tissue were 
used to look at the expression patterns of MC2R, MC5R, MRAP, and MRAP2 in the frog 
heart, brain, liver, muscle, ovaries, and intestine. The interrenal/kidney was used as a 
positive control in order to verify PCR efficiency and to compare the size of the expected 
products in the other tissues that were analyzed. For MC2R the interrenal/kidney 
(positive control) yielded the expected band of 594 base pairs (Figure 10: Lane 2). Faint 
bands were also detected in the heart (Figure 10: Lane 4) and ovaries (Figure 10: Lane 
12). In addition, an extremely faint band that was visible in muscle (Figure 10: Lane 10). 
No visible bands were detected in any of the negative controls (Figure 10: Lanes 1, 3, 5, 
7, 9, 11, 13). MC5R in interrenal/kidney (positive control) yielded the expected band of 
645 base pairs (Figure 11: Lane 2) as well as a band of a similar size in the brain, muscle, 
ovaries, and intestine (Figure 11: Lanes 6, 10, 12, 14 respectively). No visible bands were 
detected in any of the negative controls (Figure 10: Lanes 1, 3, 5, 7, 9, 11, 13). For 
MRAP, the degenerate primers yielded the expected band at about 185 base pairs for 
interrenal/kidney (Figure 12: Lane 1), but no band of a similar size was detected in any of 
the other tissues, or the negative controls. The expected product size of MRAP2 was 312  
 30 
Figure 9: MRAP nucleotide and amino acid sequence alignments of chicken (Gg) MRAP 
and X.tropicalis cDNA sequence. xt cDNA sequence was obtained from sequencing PCR 
products using degenerate primers for MRAP on cDNA synthesized from frog 
interrenal/kidney tissue. Sequences in bold show the degenerate forward primer and the 
degenerate reverse primer target sequences and identical regions are shaded gray. The 
expected product size was 185 base pairs. The amino acid alignment shows the region 
responsible for trafficking to the plasma membrane (PM) and the transmembrane 
spanning domain (TM).  
 
 
MRAP NUCLEOTIDE ALIGNMENT 
 
       DEG FORWARD PRIMER  
GgMRAP  ATGGCCAACA GAACAAACTC ATCTGAGTAC TTCTGGTCTT ATGAATATTA TTGGGATTAC  60 
xt cDNA ATGGCCAACG GAACAGACGC CTCTGAGTAC TTCTGGTCTT ATGAATATTA TTGGGATTAC  
 
 
GgMRAP  ATAGATCCAA TTCCGGTAGA TGGAAGGAAG TTGAAAGTTA ATAAATATTC TATTGTCATA 120   
xt cDNA ATAGATCCAA TTCCGGTAGA TGGAAGGAAG TTGAAAGTTA ATAAATATTC TATTGTCATA  
 
 
GgMRAP  GCCTTTTGGG TTGGACTTGC TGCCTTTGTG ATGTTTCTTT TCCTTATTTT GCTCTACATG 180 
xt cDNA GCCTTTTGGG TTGGACTTGC TGCCTTTGTG ATGTTTCTTT TC-TCATCCT GCTCTACATG  
              DEG REVERSE PRIMER 
                           
 
GgMRAP  TCCCGCTCTG GATCAAATCC AGTAAAACAG GTGGTCGTAA GGAACCGGGT AGAAGAAAGC 240 
xt cDNA TCCCG..... .......... .......... .......... .......... ..........  
 
 
 
GgMRAP AGTTCTAACA GTGAGCAGCC TCACGGTGAC AATCTCAGCA GTCCATTCCC AGATCCGGTT  300 
 
 
  
GgMRAP GCTCCCGGAA CACCCAGCTG CCTTCCAGAT CACAGTGGCA TTCATGGAAG TATTTCAGCC  360            
 
 
 
GgMRAP TGA                              363 
 
MRAP AMINO ACID ALIGNMENT 
  
                (---Traffic to PM----)             (-----Transmembrane Domain--   
GgMRAP  MANRTNSSEY FWSYEYYWDY IDPIPVDGRK LKVNKYSIVI AFWVGLAAFV MFLFLILLYM  60 
xt cDNA MANGTDASEY FWSYEYYWDY IDPIPVDGRK LKVNKYSIVI AFWVGLAAFV MFLFXILLYM  
 
 
        -) 
GgMRAP  SRSGSNPVKQ VVVRNRVEES SSNSEQPHGD NLSSPFPDPV APGTPSCLPD HSGIHGSISA 120 
xt cDNA SX........ .......... .......... .......... .......... ..........  
 
 
 
GgMRAP  * 
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Figure 10: PCR analysis of tissue distribution of X. tropicalis MC2R using cDNA 
synthesized from interrenal/kidney, heart, brain, liver, muscle, ovaries, and intestine. 
Ladder (L) sizes in base pairs listed on the right panel. Expected product size is 594 base 
pairs. Lane 1-Negative control of interrenal/kidney (no reverse transcriptase (RT)), Lane 
2-interrenal/kidney cDNA (positive control), Lane 3-Negative control of heart (no RT), 
Lane 4-heart cDNA, Lane 5-Negative control of brain (no RT), Lane 6-brain cDNA, 
Lane 7-Negative control of liver (no RT), Lane 8-liver cDNA, Lane 9-Negative control 
of muscle (no RT), Lane 10-muscle cDNA, Lane 11-Negative control of ovaries (no RT), 
Lane 12-ovaries cDNA, Lane 13-Negative control of intestine (no RT), Lane 14-intestine 
cDNA.  
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Figure 11: PCR analysis of tissue distribution of X. tropicalis MC5R using cDNA 
synthesized from interrenal/kidney, heart, brain, liver, muscle, ovaries, and intestine. 
Ladder (L) sizes in base pairs listed on the right panel. Expected product size is 645 base 
pairs. Lane 1-Negative control of interrenal/kidney (no reverse transcriptase (RT)), Lane 
2-interrenal/kidney cDNA (positive control), Lane 3-Negative control of heart (no RT), 
Lane 4-heart cDNA, Lane 5-Negative control of brain (no RT), Lane 6-brain cDNA, 
Lane 7-Negative control of liver (no RT), Lane 8-liver cDNA, Lane 9-Negative control 
of muscle (no RT), Lane 10-muscle cDNA, Lane 11-Negative control of ovaries (no RT), 
Lane 12-ovaries cDNA, Lane 13-Negative control of intestine (no RT), Lane 14-intestine 
cDNA.  
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Figure 12: PCR analysis of tissue distribution of X. tropicalis MRAP using cDNA 
synthesized from interrenal/kidney, heart, brain, liver, muscle, ovaries, and intestine. 
Ladder (L) sizes in base pairs listed on the right panel. Expected product size is 185 base 
pairs. Lane 1-interrenal/kidney cDNA (positive control, arrow points to expected band), 
Lane 2-Negative control of interrenal/kidney (no reverse transcriptase (RT)), Lane 3-
Negative control of heart (no RT), Lane 4-heart cDNA, Lane 5-Negative control of brain 
(no RT), Lane 6-brain cDNA, Lane 7-Negative control of liver (no RT), Lane 8-liver 
cDNA, Lane 9-Negative control of muscle (no RT), Lane 10-muscle cDNA, Lane 11-
Negative control of ovaries (no RT), Lane 12-ovaries cDNA, Lane 13-Negative control 
of intestine (no RT), Lane 14-intestine cDNA. 
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base pairs and was detected as expected from the interrenal/kidney tissue (Figure 13: 
Lane 2), in addition to the brain and muscle (Figure 13: Lane 6 and 9 respectively). No 
visible bands were detected in any of the negative controls (Figure 13: Lanes 1, 3, 5, 7, 
10, 11, 13). 
Since MC2R, MC5R, MRAP, and MRAP2 were found in the interrenal/kidney 
tissue of X. tropicalis, the next logical step was to analyze the pharmacological 
interaction of all of these proteins by expressing them in CHO cells. CHO cells are a 
good model system to study melanocortin receptors, because they do not endogenously 
express melanocortin receptors or the accessory proteins: MRAP and MRAP2 (Chung et 
al., 2008).  
Functional interaction of MC2R, MC5R, MRAP, and MRAP2  
CHO cells were transfected with different combinations of the receptors MC2R, 
MC5R, and the accessory proteins MRAP and MRAP2. To measure the amount of cAMP 
that was produced by MC2R and MC5R upon stimulation with either ACTH or -MSH 
all transfections were done using a CRE-luciferase reporter gene. After being stimulated 
by the respective ligand, the amount of cAMP generated by the receptors was measured 
indirectly based on the amount of luminescence produced after the luciferase substrate 
was added.  
 
Ligand selectivity of MC2R and MC5R 
To characterize the ligand selectivity of frog MC2R, CHO cells were transiently 
transfected with xtMC2R in the presence and absence of (mouse) mMRAP, and  
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Figure 13: PCR analysis of tissue distribution of X. tropicalis MRAP2 using cDNA 
synthesized from interrenal/kidney, heart, brain, liver, muscle, ovaries, and intestine. 
Ladder (L) sizes in base pairs listed on the right panel. Expected product size is 312 base 
pairs. Lane 1-Negative control of interrenal/kidney (no reverse transcriptase (RT)), Lane 
2-interrenal/kidney cDNA (positive control), Lane 3-Negative control of heart (no RT), 
Lane 4-heart cDNA, Lane 5-Negative control of brain (no RT), Lane 6-brain cDNA, 
Lane 7-Negative control of liver (no RT), Lane 8-liver cDNA, Lane 9-muscle cDNA, 
Lane 10-Negative control of muscle (no RT), Lane 11-Negative control of ovaries (no 
RT), Lane 12-ovaries cDNA, Lane 13-Negative control of intestine (no RT), Lane 14-
intestine cDNA. 
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stimulated with ACTH or -MSH. Activation of frog MC2R was only observed when the 
receptor was cotransfected with MRAP and stimulated by ACTH, but not in the absence 
of MRAP or if stimulated by -MSH (Figure 14). Next, the ligand selectivity of frog 
MC5R was analyzed by transfecting CHO cells with xtMC5R and stimulating them with 
ACTH and -MSH (Figure 15). Although it seemed that xtMC5R has a slight preference 
for ACTH (EC50 = 1.6 x 10
-9
 M) over -MSH (EC50 = 8.3 x 10
-9
 M), the difference was 
only about 5-fold (p<0.05).    
 
Effect of MRAP on MC2R and MC5R  
As previously shown, MRAP is required by xtMC2R for activation by ACTH and 
in this assay was used as a control to compare the sensitivity of MC2R vs. MC5R (Figure 
16). xtMC2R coexpressed with mMRAP (EC50 = 1.1 x 10
-10
 M) was about 10-fold more 
sensitive than xtMC5R (EC50 = 1.2 x 10
-9
 M) when stimulated with ACTH (Table 3, 
p<0.05). To test the hypothesis that MRAP will have a negative effect on MC5R 
trafficking to the plasma membrane and therefore activation of the receptor, xtMC5R was 
coexpressed with mMRAP and stimulated with ACTH (Figure 16). The coexpression of 
the frog MC5R with mMRAP made the receptor more sensitive to ACTH (EC50 = 8.7 x 
10
-11
 M) and resulted in a 13-fold shift in the EC50 value of the receptor (Table 3, 
p<0.05). There was no significant difference in EC50 values for xtMC2R and xtMC5R 
when both receptors were coexpressed with mMRAP and stimulated with ACTH. 
Similarly, to assess whether activation of xtMC5R with -MSH was affected by the 
presence of mMRAP, xtMC5R was coexpressed with mMRAP and stimulated with - 
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Figure 14: Ligand selectivity of xtMC2R. Transient transfections of CHO cells with 
xtMC2R with and without mMRAP and stimulated with frog ACTH 1-24 and frog -
MSH from 10
-12
 to 10
-6
 M. The CRE-luciferase units correspond to the amount of cAMP 
produced upon stimulation at each concentration. Each transfection was done in 
triplicates and the mean +/- S.E.M. is plotted for each data point. The EC50 value of 
xtMC2R/mMRAP stimulated with ACTH (squares) is 1.6 x 10
-10
 M +/- 3.1 x 10
-11
. Also 
shown are xtMC2R without MRAP stimulated with ACTH (circles), and xtMC2R with 
mMRAP stimulated with -MSH (diamonds).   
 38 
 
Figure 15: Ligand selectivity of xtMC5R. Transient transfections of CHO cells with 
xtMC5R and stimulated with frog ACTH 1-24 and frog -MSH from 10-12 to 10-6 M. The 
CRE-luciferase units correspond to the amount of cAMP produced upon stimulation at 
each concentration. Each transfection was done in triplicates and the mean +/- S.E.M. is 
plotted for each data point. The EC50 values are the following: xtMC5R stimulated with 
ACTH (circles) 1.6 x 10
-9
 M +/- 5.9 x 10
-10
, and xtMC5R stimulated with -MSH 
(squares) 8.3 x 10
-9
 M +/- 2.9 x 10
-9
, p=0.04. 
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Figure 16: Effect of mMRAP on xtMC2R and xtMC5R when stimulated with ACTH.  
Transient transfections of CHO cells with xtMC2R, xtMC5R, mMRAP and stimulated 
with frog ACTH 1-24 from 10
-12
 to 10
-6
 M. The CRE-luciferase units correspond to the 
amount of cAMP produced upon stimulation at each concentration. Each transfection was 
done in triplicates and the mean +/- S.E.M. is plotted for each data point. The EC50 values 
are the following: xtMC2R/mMRAP (circles) 1.1 x 10
-10
 M +/- 3.4 x 10
-11
, xtMC5R 
(squares) 1.2 x 10
-9
 M +/- 3.3 x 10
-10
, and xtMC5R/mMRAP (diamonds) 8.7 x 10
-11
 M 
+/- 2.5 x 10
-11
. Statistical analysis shown in Table 3.  
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Table 3: Statistical analysis for Figure 16. Student’s t-test for the mean EC50 values +/- 
S.E.M for the transfections shown in Figure 16. P-values listed and (*) indicates p<0.05.   
  P-value 
xtMC2R/mMRAP 
1.1 x 10
-10
 M +/- 3.4 x 10
-11
 
xtMC5R 
1.2 x 10
-9
 M +/- 3.3 x 10
-10
 
0.02* 
xtMC2R/mMRAP 
1.1 x 10
-10
 M +/- 3.4 x 10
-11
 
xtMC5R/mMRAP 
8.7 x 10
-11
 M +/- 2.5 x 10
-11
 
0.30 
xtMC5R 
1.2 x 10
-9
 M +/- 3.3 x 10
-10 
xtMC5R/mMRAP  
8.7 x 10
-11
 M +/- 2.5 x 10
-11
 
0.02* 
 
  
 41 
MSH (Figure 17). There was no significant difference in the EC50 values when xtMC5R 
(EC50 = 1.0 x 10
-8
 M) was expressed alone, or when coexpressed with mMRAP (EC50 = 
4.9 x 10
-9
 M). Figure 18 summarizes the previous observations on the effect of mMRAP 
on the ligand selectivity of xtMC5R.  
 
Effect of MRAP2 on MC2R and MC5R 
 The next step was to analyze the effect of xtMRAP2 on both xtMC2R and 
xtMC5R. Coexpression of xtMRAP2 with xtMC2R led to a 919–fold shift in the EC50 
value making the receptor significantly less sensitive to ACTH (Figure 19: EC50 = 1.0 x 
10
-7
 M) when compared to xtMC2R coexpressed with mMRAP (Figure 16: EC50 = 1.1 x 
10
-10
 M; p<0.05). In contrast, xtMRAP2 increased the sensitivity of xtMC5R to ACTH 
by about 10-fold. The EC50 value for xtMC5R shifted from 1.2 x 10
-9
 M when expressed 
alone to 1.3 x 10
-10
 M when coexpressed with xtMRAP2 (Figure 19; p<0.01). The frog 
MC5R expressed alone or coexpressed with xtMRAP2 was significantly more sensitive 
to ACTH, when either transfection is compared to the sensitivity of xtMC2R coexpressed 
with xtMRAP2 (Table 4, p<0.05). xtMC5R coexpressed with xtMRAP2 was about 803-
fold more sensitive to ACTH compared to xtMC2R with xtMRAP2. To test whether 
xtMRAP2 affected the affinity of xtMC5R to -MSH, the receptor was also coexpressed 
with xtMRAP2 and stimulated with -MSH (Figure 20). No significant difference was 
observed in the sensitivity of xtMC5R to -MSH when expressed alone (EC50 = 1.0 x 10
-
8
 M) or coexpressed with xtMRAP2 (EC50 = 2.2 x 10
-8
 M). The ligand selectivity of frog 
MC5R in the presence and absence of xtMRAP2 are summarized in Figure 21. 
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Figure 17: Effect of mMRAP on xtMC5R when stimulated with -MSH. Transient 
transfections of CHO cells with xtMC5R, mMRAP and stimulated with frog -MSH 
from 10
-12
 to 10
-6
 M. The CRE-luciferase units correspond to the amount of cAMP 
produced upon stimulation at each concentration. Each transfection was done in 
triplicates and the mean +/- S.E.M. is plotted for each data point. The EC50 values are the 
following: xtMC5R (circles) 1.0 x 10
-8
 M +/- 5.4 x 10
-9
, and xtMC5R/mMRAP (squares) 
4.9 x 10
-9
 M +/- 1.9 x 10
-9
, p=0.21. 
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Figure 18: Ligand selectivity of xtMC5R when coexpressed with and without mMRAP. 
Transient transfections of CHO cells with xtMC5R with and without mMRAP and 
stimulated with frog ACTH 1-24 and frog -MSH from 10-12 to 10-6 M. The CRE-
luciferase units correspond to the amount of cAMP produced upon stimulation at each 
concentration. Each transfection was done in triplicates and the mean +/- S.E.M. is 
plotted for each data point. The EC50 values are the following: xtMC5R stimulated with 
ACTH (circles) is 1.2 x 10
-9
 M +/- 3.3 x 10
-10
, xtMC5R/mMRAP stimulated with ACTH 
(squares) 8.7 x 10
-11
 M +/- 2.5 x 10
-11
, xtMC5R stimulated with -MSH (diamonds) is 
1.0 x 10
-8
 M +/- 5.4 x 10
-9
, xtMC5R/mMRAP stimulated with -MSH (half-filled 
squares) 4.9 x 10
-9
 M +/- 1.9 x 10
-9
.  
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Figure 19: Effect of xtMRAP2 on xtMC2R and xtMC5R when stimulated with ACTH.  
Transient transfections of CHO cells with xtMC2R, xtMC5R, xtMRAP2 and stimulated 
with frog ACTH 1-24 from 10
-12
 to 10
-6
 M. The CRE-luciferase units correspond to the 
amount of cAMP produced upon stimulation at each concentration. Each transfection was 
done in triplicates and the mean +/- S.E.M. is plotted for each data point. The EC50 values 
are the following: xtMC2R/xtMRAP2 (circles) 1.0 x 10
-7
 M +/- 3.2 x 10
-8
, xtMC5R 
(squares) 1.2 x 10
-9
 M +/- 2.2 x 10
-10
, and xtMC5R/xtMRAP2 (diamonds) 1.3 x 10
-10
 M 
+/- 5.0 x 10
-11
. Statistical analysis shown in Table 4. 
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Table 4: Statistical analysis for Figure 19. Student’s t-test for the mean EC50 values +/- 
S.E.M for the transfections shown in Figure 19. P-values listed and (*) indicates p<0.05, 
(**) indicates p<0.01.   
  P-value 
xtMC2R/xtMRAP2 
1.0 x 10
-7
 M +/- 3.2 x 10
-8
 
xtMC5R 
1.2 x 10
-9
 M +/- 2.2 x 10
-10
 
0.02* 
xtMC2R/xtMRAP2 
1.0 x 10
-7
 M +/- 3.2 x 10
-8
 
xtMC5R/xtMRAP2 
1.3 x 10
-10
 M +/- 5.0 x 10
-11
 
0.02* 
xtMC5R 
1.2 x 10
-9
 M +/- 2.2 x 10
-10 
xtMC5R/xtMRAP2  
1.3 x 10
-10
 M +/- 5.0 x 10
-11
 
0.004** 
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Figure 20: Effect of xtMRAP2 on xtMC5R when stimulated with -MSH. Transient 
transfections of CHO cells with xtMC5R, xtMRAP2 and stimulated with frog -MSH 
from 10
-12
 to 10
-6
 M. The CRE-luciferase units correspond to the amount of cAMP 
produced upon stimulation at each concentration. Each transfection was done in 
triplicates and the mean +/- S.E.M. is plotted for each data point. The EC50 values are the 
following: xtMC5R (circles) 1.0 x 10
-8
 M +/- 5.4 x 10
-9
, and xtMC5R/xtMRAP2 
(squares) 2.2 x 10
-8
 M +/- 8.3 x 10
-9
, p=0.15. 
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Figure 21: Ligand selectivity of xtMC5R when coexpressed with and without xtMRAP2. 
Transient transfections of CHO cells with xtMC5R with and without xtMRAP2 and 
stimulated with frog ACTH 1-24 and frog -MSH from 10-12 to 10-6 M. The CRE-
luciferase units correspond to the amount of cAMP produced upon stimulation at each 
concentration. Each transfection was done in triplicates and the mean +/- S.E.M. is 
plotted for each data point. The EC50 values are the following: xtMC5R stimulated with 
ACTH (circles) is 1.2 x 10
-9
 M +/- 3.3 x 10
-10
, xtMC5R/xtMRAP2 stimulated with ACTH 
(squares) 1.3 x 10
-10
 M +/- 7.7 x 10
-11
, xtMC5R stimulated with -MSH (diamonds) is 
1.0 x 10
-8
 M +/- 5.4 x 10
-9
, xtMC5R/xtMRAP2 stimulated with -MSH (half-filled 
squares) 2.2 x 10
-8
 M +/- 8.3 x 10
-9
.  
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Since the cloning experiments revealed a small region of MRAP that was highly 
similar to the chicken MRAP, it made sense to test the effect of chicken MRAP on the 
ligand selectivity of MC5R. Consistent with experiments using the mouse MRAP, the 
chicken MRAP also increased the sensitivity of xtMC5R to ACTH and caused a 383-fold 
shift in the EC50 value from 1.5 x 10
-9 
M to 3.8 x 10
-12
 M (Figure 22; p<0.05). The effect 
that the chicken MRAP had on xtMC5R was comparable to the effect that xtMRAP2 had 
on xtMC5R when stimulated with ACTH. On the other hand, neither chicken MRAP or 
xtMRAP2 changed the sensitivity of xtMC5R to -MSH (Figure 23). 
 
Effect of both MRAPs on MC2R and MC5R 
 Due to previous findings that have shown that MRAP and MRAP2 have the 
ability to form a heterodimer (Chan et al., 2009), both xtMC2R and xtMC5R were 
coexpressed with mMRAP and xtMRAP2. There was no change in the sensitivity of 
xtMC2R to ACTH when the receptor was coexpressed with both mMRAP and xtMRAP2 
(Figure 24). However, there was about three times more cAMP produced when xtMC2R 
was coexpressed with both MRAPs (p<0.001). Both MRAPs coexpressed with xtMC5R 
increased the sensitivity of the receptor to ACTH (Figure 25; p<0.05). Coexpression of 
both MRAPs with xtMC5R caused a shift in the EC50 value from 1.2 x 10
-9
 M to 8.0 x 10
-
11
 M, and resulted in a slight but significant increase in cAMP (p<0.001). There was no 
significant difference in the sensitivity of the receptor when xtMC5R was coexpressed 
with both MRAPs and stimulated with -MSH (Figure 26), but there was over twice as 
much cAMP produced (p<0.001).  
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Figure 22: Effect of chicken MRAP and xtMRAP2 on xtMC5R when stimulated with 
ACTH. Transient transfections of CHO cells with xtMC5R, chicken MRAP, xtMRAP2 
and stimulated with frog ACTH 1-24 from 10
-12
 to 10
-6
 M. The CRE-luciferase units 
correspond to the amount of cAMP produced upon stimulation at each concentration. 
Each transfection was done in triplicates and the mean +/- S.E.M. is plotted for each data 
point. The EC50 values are the following: xtMC5R (circles) 1.5 x 10
-9 
M +/- 5.5 x 10
-10
, 
xtMC5R/chicken MRAP (squares) 3.8 x 10
-12
 M +/- 3.4 x 10
-12
, and xtMC5R/xtMRAP2 
(diamonds) 3.4 x 10
-11
 M +/- 1.5 x 10
-11
. Statistical analysis shown in Table 5. 
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Table 5: Statistical analysis for Figure 22. Student’s t-test for the mean EC50 values +/- 
S.E.M for the transfections shown in Figure 22. P-values listed and (*) indicates p<0.05.   
  P-value 
xtMC5R 
1.5 x 10
-9 
M +/- 5.5 x 10
-10
 
xtMC5R/chicken MRAP 
3.8 x 10
-12
 M +/- 3.4 x 10
-12
 
0.03* 
xtMC5R 
1.5 x 10
-9 
M +/- 5.5 x 10
-10
 
xtMC5R/xtMRAP2 
3.4 x 10
-11
 M +/- 1.5 x 10
-11
 
0.03* 
xtMC5R/chicken MRAP 
3.8 x 10
-12
 M +/- 3.4 x 10
-12 
xtMC5R/xtMRAP2 
3.4 x 10
-11
 M +/- 1.5 x 10
-11
 
0.06 
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Figure 23: Effect of chicken MRAP and xtMRAP2 on xtMC5R and stimulated with -
MSH. Transient transfections of CHO cells with xtMC5R, chicken MRAP, xtMRAP2 
and stimulated with frog -MSH from 10-12 to 10-6 M. The CRE-luciferase units 
correspond to the amount of cAMP produced upon stimulation at each concentration. 
Each transfection was done in triplicates and the mean +/- S.E.M. is plotted for each data 
point. The EC50 values are the following: xtMC5R (circles) 1.1 x 10
-8 
M +/- 7.0 x 10
-9
, 
xtMC5R/chicken MRAP (squares) 2.2 x 10
-9
 M +/- 1.3 x 10
-9
, and xtMC5R/xtMRAP2 
(diamonds) 1.6 x 10
-8
 M +/- 4.9 x 10
-9
. Statistical analysis shown in Table 6. 
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Table 6: Statistical analysis for Figure 23. Student’s t-test for the mean EC50 values +/- 
S.E.M for the transfections shown in Figure 23. P-values listed and (*) indicates p<0.05.   
  P-value 
xtMC5R 
1.1 x 10
-8 
M +/- 7.0 x 10
-9
 
xtMC5R/chicken MRAP 
2.2 x 10
-9
 M +/- 1.3 x 10
-9
 
0.15 
xtMC5R 
1.1 x 10
-8 
M +/- 7.0 x 10
-9
 
xtMC5R/xtMRAP2 
1.6 x 10
-8
 M +/- 4.9 x 10
-9
 
0.30 
xtMC5R/chicken MRAP 
2.2 x 10
-9
 M +/- 1.3 x 10
-9 
xtMC5R/xtMRAP2 
1.6 x 10
-8
 M +/- 4.9 x 10
-9
 
0.03* 
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Figure 24: Effect of mMRAP and xtMRAP2 on xtMC2R when stimulated with ACTH.  
Transient transfections of CHO cells with xtMC2R, mMRAP, xtMRAP2 and stimulated 
with frog ACTH 1-24 from 10
-12
 to 10
-6
 M. The CRE-luciferase units correspond to the 
amount of cAMP produced upon stimulation at each concentration. Each transfection was 
done in triplicates and the mean +/- S.E.M. is plotted for each data point. The EC50 values 
are the following: xtMC2R/mMRAP (circles) 1.1 x 10
-10
 M +/- 3.4 x 10
-11
, and 
xtMC2R/mMRAP/xtMRAP2 (squares) 2.0 x 10
-10
 M +/- 1.1 x 10
-10
, p=0.24. 
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Figure 25: Effect of mMRAP and xtMRAP2 on xtMC5R when stimulated with ACTH. 
Transient transfections of CHO cells with xtMC5R, mMRAP, xtMRAP2 and stimulated 
with frog ACTH 1-24 from 10
-12
 to 10
-6
 M. The CRE-luciferase units correspond to the 
amount of cAMP produced upon stimulation at each concentration. Each transfection was 
done in triplicates and the mean +/- S.E.M. is plotted for each data point. The EC50 values 
are the following: xtMC5R (circles) 1.2 x 10
-9
 M +/- 3.3 x10
-10
, and 
xtMC5R/mMRAP/xtMRAP2 (squares) 8.0 x 10
-11
 M +/- 3.1 x 10
-11
, p=0.02. 
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Figure 26: Effect of mMRAP and xtMRAP2 on xtMC5R and stimulated with -MSH. 
Transient transfections of CHO cells with xtMC5R, mMRAP, xtMRAP2 and stimulated 
with frog -MSH from 10-12 to 10-6 M. The CRE-luciferase units correspond to the 
amount of cAMP produced upon stimulation at each concentration. Each transfection was 
done in triplicates and the mean +/- S.E.M. is plotted for each data point. The EC50 values 
are the following: xtMC5R (circles) 2.3 x 10
-8
 M +/- 1.0 x 10
-8
, and 
xtMC5R/mMRAP/xtMRAP2 (squares) 1.2 x 10
-8
 M +/- 4.1 x 10
-9
, p=0.20. 
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Interaction of MC2R, MC5R, MRAP, and MRAP2 
After analyzing the effect of MRAP and MRAP2 on each individual receptor, the 
interaction of all these proteins was examined. CHO cells were transfected with xtMC2R, 
xtMC5R, mMRAP, and xtMRAP2 and stimulated with ACTH (Figure 27). The EC50 
value was 1.4 x 10
-10
 M and was comparable to the control xtMC2R and mMRAP (1.1 x 
10
-10
 M); however, the level of cAMP was four times as much when all proteins were 
expressed (p<0.001).  The contribution of xtMC2R/mMRAP was studied by using a 
mutant xtMC2R receptor in which the isoleucine at position 175 had been substituted by 
an alanine (xtMC2R I-175) (Figure 28). When compared to wild type MC2R, the mutant 
MC2R I-175 was not nearly as efficient as the wild type MC2R when stimulated by 
ACTH (p<0.01). There was a 526-fold shift in response to ACTH from an EC50 of 3.1 x 
10
-10
 M from the wild type receptor to an EC50 of 1.6 x 10
-7
 M from the mutant receptor. 
Even if the mutant receptor xtMC2R I-175 was coexpressed with both MRAPs, the 
mutant receptor was not nearly as efficient as the wild type receptor (p<0.01).  
Coexpression of mutant MC2R I-175 with xtMRAP2 completely abolished activation by 
ACTH. Mutant xtMC2R I-175 coexpressed with xtMC5R, mMRAP, and xtMRAP2 
resulted in a similar EC50 value compared to wild type xtMC2R, but did not result in a 
significant increase cAMP (p>0.05).   
Likewise, expression of xtMC2R, xtMC5R, mMRAP, and xtMRAP2 were 
compared to xtMC5R (Figure 29). The receptor on its own was sixteen times less 
sensitive to ACTH and had an EC50 of 1.2 x 10
-9
 M versus an EC50 of 7.2 x 10
-11
 M when 
coexpressed with MC2R and both MRAPs (p<0.05). When both receptors and both  
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Figure 27: Transient transfection of CHO cells with xtMC2R, xtMC5R, mMRAP, 
xtMRAP2 compared to xtMC2R/mMRAP when stimulated with frog ACTH 1-24 from 
10
-12
 to 10
-6
 M. The CRE-luciferase units correspond to the amount of cAMP produced 
upon stimulation at each concentration. Each transfection was done in triplicates and the 
mean +/- S.E.M. is plotted for each data point. The EC50 values are the following: 
xtMC2R/mMRAP (circles) 1.1 x 10
-10
 M +/- 3.4 x 10
-11
, and 
xtMC2R/mMRAP/xtMRAP2/xtMC5R (squares) 1.4 x 10
-10
 M +/- 4.9 x 10
-11
, p=0.34. 
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Figure 28: Contribution of wild type xtMC2R/mMRAP when stimulated with ACTH. 
Transient transfection of CHO cells with mutant xtMC2R I-175, xtMC5R, mMRAP, and 
xtMRAP2 compared to wild type xtMC2R when stimulated with frog ACTH 1-24 from 
10
-12
 to 10
-6
 M. The CRE-luciferase units correspond to the amount of cAMP produced 
upon stimulation at each concentration. Each transfection was done in triplicates and the 
mean +/- S.E.M. is plotted for each data point. The EC50 values are the following: 
xtMC2R/mMRAP (filled circles) 3.1 x 10
-10
 M +/- 2.8 x 10
-11
, xtMC2R I-175/mMRAP 
(squares) 1.6 x 10
-7
 M +/- 3.3 x 10
-8
, xtMC2R I-175/mMRAP/xtMRAP2 (half-filled 
squares) 1.2 x 10
-7
 M +/- 2.9 x 10
-8
, xtMC2R I-175/mMRAP/xtMRAP2/xtMC5R (open 
circles) 2.0 x 10
-9
 M +/- 1. 9 x 10
-9
.  Also shown xtMC2R I-175/xtMRAP2 (triangles). 
Statistical analysis shown in Table 7. 
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Table 7: Statistical analysis for Figure 28. Student’s t-test for the mean EC50 values +/- 
S.E.M for the transfections shown in Figure 28. P-values listed and (*) indicates p<0.05, 
(**) indicates p<0.01.     
  P-value 
xtMC2R/mMRAP  
3.1 x 10
-10
 M +/- 2.8 x 10
-11
 
xtMC2R I-175/mMRAP  
1.6 x 10
-7
 M +/- 3.3 x 10
-8
 
0.004** 
xtMC2R/mMRAP 
3.1 x 10
-10
 M +/- 2.8 x 10
-11
 
xtMC2R I-175/ 
mMRAP/xtMRAP2 
1.2 x 10
-7
 M +/- 2.9 x 10
-8
 
0.007** 
xtMC2R/mMRAP 
3.1 x 10
-10
 M +/- 2.8 x 10
-11 
xtMC2R I-175/ 
mMRAP/xtMRAP2/xtMC5R 
2.0 x 10
-9
 M +/- 1.9 x 10
-9
 
0.21 
xtMC2R I-175/ 
mMRAP/xtMRAP2/xtMC5R 
2.0 x 10
-9
 M +/- 1.9 x 10
-9 
xtMC2R I-175/mMRAP  
1.6 x 10
-7
 M +/- 3.3 x 10
-8 
0.004** 
xtMC2R I-175/ 
mMRAP/xtMRAP2/xtMC5R 
2.0 x 10
-9
 M +/- 1.9 x 10
-9 
xtMC2R I-175/ 
mMRAP/xtMRAP2 
1.2 x 10
-7
 M +/- 2.9 x 10
-8 
0.007** 
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Figure 29: Transient transfection of CHO cells with xtMC2R, xtMC5R, mMRAP, 
xtMRAP2 compared to xtMC5R when stimulated with frog ACTH 1-24 from 10
-12
 to 10
-
6
 M. The CRE-luciferase units correspond to the amount of cAMP produced upon 
stimulation at each concentration. Each transfection was done in triplicates and the mean 
+/- S.E.M. is plotted for each data point. The EC50 values are the following: xtMC2R 
(circles) 1.2 x 10
-9
 M +/- 3. 3 x 10
-10
, and xtMC2R/mMRAP/xtMRAP2/xtMC5R 
(squares) 7.2 x 10
-11
 M +/- 4.0 x 10
-11
, p=0.01. 
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accessory proteins were expressed together they produced almost five times more cAMP 
than xtMC5R by itself (p<0.001). To study this interaction further, a mutant xtMC5R 
with alanine substitutions at amino acid positions 92, 114, and 119 (xtMC5R 
A/92/114/119) was coexpressed with xtMC2R, mMRAP, and xtMRAP2 and compared to 
wild type xtMC5R (Figure 30). Mutant xtMC5R A92/114/119 alone or coexpressed with 
any of the MRAPs failed to be activated by ACTH. The coexpression of mutant xtMC5R 
A/92/114/119 with xtMC2R, mMRAP, and xtMRAP2 did not result in a significant shift 
in the EC50 value when compared the wild type xtMC5R. However there was about five 
and a half times more cAMP produced when mutant xtMC5R A92/114/119 was 
coexpressed with xtMC2R, mMRAP, and xtMRAP2.  
In contrast, expression of xtMC5R alone compared to expression of xtMC5R, 
xtMC2R, mMRAP, and xtMRAP2 did not change sensitivity to -MSH (Figure 31). The 
EC50 value remained in the 10
-8
 M range.  
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Figure 30: Contribution of wild type xtMC5R when stimulated with ACTH. Transient 
transfection of CHO cells with mutant xtMC5R A92/114/119, xtMC2R, mMRAP, and 
xtMRAP2 compared to wild type xtMC5R when stimulated with frog ACTH 1-24 from 
10
-12
 to 10
-6
 M. The CRE-luciferase units correspond to the amount of cAMP produced 
upon stimulation at each concentration. Each transfection was done in triplicates and the 
mean +/- S.E.M. is plotted for each data point. The EC50 values are the following: 
xtMC5R (circles) 9.8 x 10
-10
 M +/- 5.4 x 10
-10
, and xtMC5R 
A92/114/119/xtMC2R/mMRAP/xtMRAP2 (half-filled squares) 8.9 x 10
-10
 M +/- 2.8 x 
10
-10
. Also shown are xtMC5R A92/114/119 (squares) and xtMC5R 
A92/114/119/xtMC2R/mMRAP/xtMRAP2 (triangles), P-value between xtMC5R and 
xtMC5R A92/114/119/xtMC2R/mMRAP/xtMRAP2, p=0.45. 
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Figure 31: Transient transfection of CHO cells with xtMC2R, xtMC5R, mMRAP, and 
xtMRAP2 compared to xtMC5R when stimulated with frog -MSH from 10-12 to 10-6 M. 
The CRE-luciferase units correspond to the amount of cAMP produced upon stimulation 
at each concentration. Each transfection was done in triplicates and the mean +/- S.E.M. 
is plotted for each data point. The EC50 values are the following: xtMC5R (circles) 1.0 x 
10
-8
 M +/- 5.4 x 10
-9
, and xtMC5R/mMRAP/xtMRAP2/xtMC2R (squares) 7.7 x 10
-8
 M 
+/- 3.4 x 10
-8
, p=0.06. 
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Discussion 
The primary aim of this study was to understand the role of melanocortin 
receptors (MC2R and MC5R) and the accessory proteins (MRAP and MRAP2) in the 
HPI-axis of the amphibian Xenopus tropicalis, and to test whether the function of this 
system is similar to the mammalian HPA-axis. It was hypothesized that X. tropicalis 
MC2R, MC5R, MRAP, and MRAP2 would be expressed in the interrenal gland. 
Additionally, it was predicted that the interaction of these proteins would be comparable 
to what Sebag and Hinkle (2009a) previously published for the mammalian MC2R, 
MC5R, MRAP, and MRAP2 in the adrenal gland. Based on their observations MRAP 
should facilitate trafficking of X. tropicalis MC2R to the plasma membrane and enable 
activation by ACTH, but MRAP and MRAP2 should inhibit cell surface expression of 
MC5R and no activation should be achieved by either ACTH or -MSH. In this study 
RT-PCR performed on the interrenal/kidney tissue of the frog confirmed the expression 
of MC2R, MC5R, MRAP, and MRAP2. Furthermore, through testing the interaction of 
these four proteins in vitro it was verified that MRAP was required for MC2R activation 
by ACTH, but unlike the mammalian system MRAP and MRAP2 did not inhibit MC5R 
activation by ACTH or -MSH.  
 
 
 65 
Cloning and expression patterns of MC2R, MC5R, MRAP, MRAP2  
 The results obtained from PCR and sequencing verified the presence of MC2R, 
MC5R, MRAP, and MRAP2 in the frog interrenal/kidney tissue (See Figures 5-9). This 
fits in line with earlier studies that have shown coexpression of MC2R and MC5R in 
other organisms including the adrenals in mammals (Sebag and Hinkle, 2009a), and the 
head kidney of fish (Kobayashi et al., 2011). The significance of the coexpression of 
MC2R and MC5R in the same cell type could be the result of the proposed common 
origin of these two receptors (See Figure 32). It has been hypothesized that MC2R and 
MC5R are the result of a local gene duplication that occurred in an MC2R/MC5R gene 
(Dores, 2013). This could provide a possible explanation as to why both receptors were 
found in the interrenal tissue of the frog. The two accessory proteins MRAP and MRAP2 
were also found in the interrenal/kidney tissue. Since MRAP has not yet been identified 
in the X. tropicalis genome, degenerate primers designed from conserved regions of 
MRAP were used in the PCR reaction. From the sequencing results, a 185 base pair 
region of MRAP was obtained that matched the chicken MRAP sequence (Figure 9). This 
region contains the domain that is responsible for facilitating MC2R trafficking to the 
plasma membrane and the transmembrane spanning domain (Liang et al., 2011). The 
sequenced portion of X. tropicalis MRAP was highly similar to the chicken MRAP both 
at the nucleotide and amino acid level. For MRAP the N-terminal region and 
transmembrane spanning domain are highly conserved and the region cloned from the 
frog interrenal was almost identical to the chicken MRAP. Currently the sequencing of  
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Figure 32: Proposed outline for the evolution of melanocortin receptors (MCRs). This 
diagram shows the prediction of how two genome duplication events and one local gene 
duplication could have given rise to the five known MCRs. This schematic predicts that 
MC4R was the ancestral MCR. Receptors in a dashed box have not yet been identified 
and the dashed lines indicate the hypothesis that melanocortin receptors 2 and 5 are the 
result of a local gene duplication from an MC2R/MC5R gene. (Figure adapted from 
Dores, 2013). 
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MRAP from the interrenal tissue is being repeated to ensure that the results obtained here 
were not due to contamination. 
One caveat to the results obtained from the RT-PCR experiments is that due to the 
difficulty of extracting the interrenal tissue, a small portion of the kidney had to be 
extracted along with it; therefore, the possibility that some of these genes were cloned 
from the small portion of the kidney cannot be ruled out. Another factor that must be 
considered is that although both receptors and accessory proteins were cloned from the 
interrenal tissue, these results do not provide definitive proof that all four genes are being 
expressed in the glucocorticoid producing cells. 
After determining that the primers for MC2R, MC5R, MRAP, and MRAP2 had 
amplified the target sequence, the primers were tested on other frog tissues to look at the 
expression pattern of these genes (Figures 10-13). The tissues analyzed were 
interrenal/kidney, heart, brain, liver, muscle, ovaries, and intestine. Expression of MC2R 
was positive for the interrenal/kidney, heart, ovaries, and a very faint band was observed 
in muscle (Figure 10). Expression in the interrenal tissue and ovaries of the frog is 
consistent with tissue expression studies of MC2R in mice (Nimura et al., 2006) and in 
fish (Aluru and Vijayan, 2008) that have shown that MC2R is also found in the 
adrenal/interrenal tissue and the ovaries/testis of these organisms. The next gene to be 
analyzed in the frog was MC5R and expression was detected in the interrenal/kidney, 
brain, muscle, ovaries, and intestine (Figure 11). These findings are in agreement with 
several studies in mammals that have shown that MC5R has the widest range of tissue 
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distribution (Gantz et al, 1994; Fathi et al., 1995; Chen et al., 1997; Nimura et al., 2006). 
These studies have found varying levels of expression of MC5R in the mouse adrenal 
gland, exocrine glands, RT2-2 retinal neuronal cells, muscle, skin, spinal cord, brain 
stem, kidney, testis, heart, liver, lung, spleen, and adipose tissue. To this date, the only 
known function that has been determined for MC5R in mammals is its role in exocrine 
gland secretion (Chen et al., 1997), but its role in the other tissues and other species is 
still unknown. One important observation from this earlier study was that the HPA-axis 
of MC5R knock-out mice was intact, suggesting that in mammals MC5R is not involved 
in glucocorticoid secretion despite being found in the adrenal gland. For MRAP, other 
than the interrenal/kidney tissue, the degenerate primers failed to detect expression in the 
other frog tissues that were analyzed (Figure 12). Failure to detect MRAP in the other 
frog tissues could be due to lack of expression, lower expression, or nonspecific binding 
of the degenerate primers. To increase the specificity of this screening method, the full-
length sequence of the frog MRAP must be obtained so that gene specific primers can be 
designed and these tissues can be screened again. Lastly MRAP2 primers were tested in 
the various frog tissues and it was found in interrenal/kidney, brain, and muscle (Figure 
13). The team of researchers that discovered MRAP2 showed that it was expressed in the 
human brain and adrenal gland (Chan et al., 2009). This group of researchers also showed 
that both MRAP and MRAP2 could interact with all five members of the melanocortin 
receptor family to regulate their function. A relevant example of this is a recent study 
done in which it was shown that MRAP2 proteins alter the function of MC4R in the brain 
to regulate energy homeostasis during the development of zebrafish (Sebag et al., 2013). 
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Therefore, finding MRAP2 in the frog brain was not surprising and it is likely that 
MRAP2 could also involved in regulating the function of the frog MC4R in the brain.       
 
Modeling the interaction of frog MC2R, MC5R, MRAP, MRAP2 in CHO cells 
Another objective of the present study was to recreate the internal environment of 
the frog interrenal cell. This was implemented through transient transfections of CHO 
cells with varying combinations of xtMC2R, xtMC5R, mMRAP, and xtMRAP2 and 
stimulating the cells with ACTH or -MSH. This was done to enable the characterization 
of the functional interaction of the proteins involved in glucocorticoid secretion during 
activation of the HPI-axis. Collectively, the observations from the transfection 
experiments give indication that the interaction of MC2R, MC5R, MRAP, and MRAP2 
in Xenopus tropicalis differs from the mammalian system, specifically with respect to the 
function of MC5R.  
First, it was shown that similar to mammals, functional activation of the frog 
MC2R by ACTH requires coexpression with MRAP, and that despite coexpression of 
xtMC2R with MRAP no activation was observed when the cells were stimulated with -
MSH (Figure 14). The ligand selectivity of MC2R for ACTH and requirement for MRAP 
has been well established for mammals, birds, reptiles, and amphibians (Barlock et al., 
2014; Agulleiro et al., 2010; Liang et al., 2011; Davis et al., 2013). In addition, the 
HFRW and KKRRP motifs on ACTH have been shown to be important for proper 
activation of MC2R (Costa et al., 2004; Davis et al., 2013). This means that MC2R must 
have a binding site not only for the HFRW domain of ACTH, but also for KKRRP, which 
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is not present in any of the MSH-ligands. Another similarity to the mammalian MC2R is 
that MRAP2 did not completely abolish activation of xtMC2R to ACTH, but greatly 
reduced the sensitivity of the receptor (Figure 19). This is consistent with the finding that 
MRAP2 can interact with MC2R, but it is not nearly as efficient as MRAP for trafficking 
to the plasma membrane or functional activation by ACTH (Chan et al., 2009).   
Subsequently it was determined that unlike the mammalian MC5R, the function 
of the amphibian MC5R was not inhibited by the presence of MRAPs. When xtMC5R 
was coexpressed with MRAP, MRAP2, or a combination of both MRAPs, the receptor 
became significantly more sensitive to ACTH (See Figures 16,19, 22, 25). From the 
sequencing results, it was not surprising that the chicken MRAP had the greatest effect on 
xtMC5R and increased the sensitivity to ACTH by three orders of magnitude from 1.5 x 
10
-9 
M (alone) to 3.8 x 10
-12
 M (with MRAP) (Figure 22). Interestingly, when either 
MC2R or MC5R were coexpressed with both MRAPs and stimulated with ACTH, the 
amount of cAMP produced was 2-3 times as much (See Figures 24 and 25). This can be 
an indication that the receptor might be interacting with an MRAP-MRAP2 heterodimer, 
but further studies must be done to confirm this interaction. Then, even though xtMC5R 
had a slight preference for ACTH over -MSH (Figure 15), the effect of MRAPs on 
MC5R was also tested when the cells were stimulated with -MSH (See Figures 17, 20, 
23, 26). The coexpression of xtMC5R with any of combination of MRAPs did not change 
the sensitivity of the receptor to -MSH in either a positive or a negative manner. The 
EC50 value of the receptor remained virtually the same regardless of the presence of 
MRAPs when xtMC5R was stimulated with -MSH.  
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Finally, the interaction of MC2R, MC5R, MRAP, and MRAP2 was analyzed by 
transfecting CHO cells with equal amounts of each cDNA construct and stimulating with 
ACTH or -MSH. When stimulated with ACTH, the EC50 value obtained when both 
receptors and both accessory proteins were present was comparable to xtMC2R/mMRAP 
(Figure 27), but when compared to xtMC5R (Figure 29) the EC50 value of all four 
proteins was significantly more sensitive. Under both circumstances the amount of cAMP 
produced was 4-5 times higher in the presence of both receptors and both accessory 
proteins, compared to each receptor on its own. This indicates that both receptors may be 
contributing to the overall response when stimulated with ACTH, and that the 
combination of both accessory proteins does not have a negative effect on the function of 
the receptors. On the other hand, there was no significant difference when the cells were 
transfected with xtMC5R alone or when transfected with a combination of xtMC2R, 
xtMC5R, mMRAP, and xtMRAP2 and stimulated with -MSH (Figure 31). This is due 
to the fact that xtMC2R cannot be activated by -MSH, and that the MRAPs do not have 
an effect on MC5R when the receptor is stimulated with -MSH. Therefore, the response 
to -MSH comes only from the presence of xtMC5R.   
To further understand the interaction of MC2R, MC5R, MRAP, and MRAP2 and 
to assess the contribution of each receptor, studies were done using a mutant xtMC2R I-
175 receptor (Figure 28) and a mutant xtMC5R A92/114/119 receptor (Figure 30). The 
mutant xtMC2R I-175 has an alanine substitution at isoleucine position 175. This mutant 
MC2R receptor coexpressed with mMRAP (EC50= 1.6 x 10
-7
 M) has a greatly reduced 
sensitivity to ACTH compared to the wild type MC2R with mMRAP (Figure 28; EC50= 
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3.1 x 10
-10
 M; p<0.01). The interaction of xtMC2R I-175 with xtMRAP2 completely 
eliminated activation by ACTH, and coexpression with both MRAPs did not change the 
sensitivity of the mutant receptor. When the mutant MC2R I-175 is coexpressed with 
MC5R and both MRAPs, the response to ACTH was similar to wild type MC2R with 
MRAP. This was interesting since mutations can occur in the frog MC2R where ACTH 
no longer activates this receptor, but the presence of MC5R and the interaction with 
MRAPs almost restores functional activation by ACTH similar to wild type 
MC2R/mMRAP. Then, studies were done using a mutant MC5R. The mutant xtMC5R 
A92/114/119 has alanine substitutions at amino acid positions 92, 114, 119. These 
mutations lie in the transmembrane 2 and transmembrane 3 domains (TM2/TM3) of 
MC5R, which are amino acid residues involved in the binding pocket of the receptor 
(Yang, 2011). This mutant MC5R did not respond at all to ACTH, alone or in the 
presence of MRAPs (Figure 30). However, addition of xtMC2R restores activation by 
ACTH and this response was only from activation of xtMC2R, since the mutant xtMC5R 
A92/114/119 does not respond to ACTH. When the interaction of xtMC2R, MRAP, 
MRAP2, and mutant xtMC5R A92/114/119 is compared to what the wild type xtMC5R 
would contribute, it becomes evident that the majority of the cAMP response to ACTH 
comes from activation of xtMC2R. Additional studies, such as Co-Immunoprecipitation 
(Co-IP), must be performed in order to confirm that this mutant MC5R does interact with 
MC2R and the MRAPs, and that this receptor is not being degraded or retained in the ER 
due to improper folding. 
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Conclusion 
Taken together, the results obtained here confirm the hypothesis that all four 
proteins MC2R, MC5R, MRAP, and MRAP2 are found in the frog interrenal tissue. Also, 
it was confirmed that the interaction of the frog MC2R with MRAP would allow 
functional activation of the receptor by ACTH. However, the hypothesis that MRAP and 
MRAP2 would have a negative effect on MC5R must be rejected based on the 
observations that MRAP and MRAP2 increased the sensitivity of MC5R to ACTH, and 
did not change the sensitivity of the receptor to -MSH. When all four proteins were 
coexpressed in CHO cells and stimulated with ACTH, the response observed seemed to 
be a combined effect of both MC2R and MC5R interacting with MRAP and MRAP2. 
From these observations it can be said that at least in vitro, the frog MC5R contributes to 
the overall production of cAMP. If this holds true in vivo it means that MC5R also 
contributes to glucocorticoid secretion during activation of the HPI-axis. 
Nevertheless, the results obtained in this study still leave unresolved the 
observation that -MSH does not induce glucocorticoid secretion in vivo (Schwyzer, 
1977; Aluru and Vijayan 2008; Kobayashi et al., 2011). Although in mammals the second 
highest concentration of the antagonist AGRP has been found in the adrenal gland, 
MC2R and MC5R have no affinity for this antagonist (Gantz and Fong, 2003). A possible 
mechanism for the selectivity of ACTH over -MSH in the mammalian adrenal cell 
could be due to the negative effect that MRAPs have on the cell surface expression of 
MC5R. If MC5R cannot reach the cell surface, then it cannot be functionally activated by 
-MSH to induce glucocorticoid secretion during the stress response. This does not seem 
 74 
to be the case for regulating the ligand selectivity in the frog interrenal cell. It is possible 
that in the frog, the levels of -MSH required for activation of MC5R in the interrenal 
cell are extremely high, (10
-8 
M range) which begins to get above physiological levels. 
Even if the concentration of -MSH were to reach these levels in vivo, this ligand would 
preferentially bind to and activate MCRs that are more sensitive to -MSH, such as 
MC1R.  
 
Future directions  
The studies presented here only begin to examine the interactions between MC2R, 
MC5R, MRAP, and MRAP2, but future studies should be done to further understand the 
interaction of these proteins in the frog interrenal cells. First, the sequence of MRAP 
should be verified and the full-length MRAP gene should be sequenced. This can be done 
through performing 3’ and 5’ RACE (Rapid amplification of cDNA ends) reactions on 
the interrenal cDNA to obtain the 3’ and 5’ ends of the frog MRAP gene. Next, 
Quantitative RT-PCR (qRT-PCR) can be done to measure the expression levels of 
MC2R, MC5R, MRAP, and MRAP2 in the frog interrenal cells. It could be that MC2R 
has higher expression levels than MC5R and this could explain why -MSH does not 
induce cortisol secretion in vivo. An earlier study showed that ACTH upregulates 
expression levels of MC2R in mice and human cell lines (Mountjoy et al., 1994). 
Therefore, the frog MC2R and MC5R expression levels could be measured by qRT-PCR 
before and after stimulation by ACTH. Additionally, in situ hybridization using RNA 
probes could be done on the frog interrenal tissue to determine if MC2R, MC5R, MRAP, 
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and MRAP2 are all expressed in the glucocorticoid producing cells. Another experiment 
that can be performed is cell surface ELISA to measure the amount of receptor (MC2R or 
MC5R) that reaches the cell surface in the presence and absence of MRAPs. Then 
another method for analyzing these interactions can be applied such as fluorescent 
immunocytochemistry to show the co-localization of the receptors and accessory 
proteins. Moreover, it has been shown that other members of the melanocortin receptor 
family can form homo- and heterodimers (Mandrika et al., 2005) and Co-IP can be done 
to determine whether frog MC2R/MC5R can form heterodimers. In this study, the 
pharmacological properties of xtMC2R and xtMC5R when stimulated with ACTH or -
MSH were also tested, but in either case the response was similar to xtMC5R being 
expressed alone (data not shown); however it is possible that MC2R/MC5R do form a 
heterodimer. Co-IP can also be used to show that MC2R, MC5R, MRAP, and MRAP2 
have the potential to form a complex in vitro, and that this complex might also be formed 
in vivo. The work presented here and future work that remains to be done, will help to 
provide a further understanding of how the HPA/I-axis has evolved, and the role of 
melanocortin receptors and accessory proteins in regulating the function of this system.   
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